Short communicationDextrorphan, but not dextromethorphan, exerts weak antidystonic effects in mutant dystonic hamsters

Add time:09/27/2019    Source:sciencedirect.com

The effects of dextromethorphan and its metabolite dextrorphan on severity of dystonia were examined in mutant dystonic hamsters, an animal model of idiopathic paroxysmal dystonia, in which recent examinations have shown antidystonic effects of selective N-methyl-d-aspartate (NMDA) receptor antagonists. Dextromethorphan and dextrorphan are non-competitive NMDA receptor antagonists which additionally exhibit affinity for sigma receptors. Dextrorphan (20 and 40 mg/kg i.p) significantly retarded the progression of dystonia at the higher dose, whereas dextromethorphan (20, 40, 60 mg/kg i.p.) failed to exert any antidystonic effects even at high doses which caused severe side effects. The lack of antidystonic efficacy of dextromethorphan may be related to its higher affinity to sigma receptors compared with dextrorphan.

We also recommend Trading Suppliers and Manufacturers of DEXTRORPHAN D-TARTRATE (cas 125-73-5). Pls Click Website Link as below: cas 125-73-5 suppliers

Prev:Determination of dextromethorphan and its metabolite dextrorphan in human urine by capillary gas chromatography without derivatization
Next:Development of a chromatographic bioreactor based on immobilized β-glucuronidase on monolithic support for the determination of dextromethorphan and dextrorphan in human urine)